8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 22, 2018

Dex Liquidating Co.

(Exact Name of Registrant as Specified in its Charter)

Delaware (State or Other Jurisdiction of Incorporation) 000-51772 (Commission File Number) 94-3287832 (IRS Employer Identification No.)

7 West 41^st Avenue - #245, San Mateo, CA (Address of Principal Executive Offices) 94403 (Zip Code)

Registrant’s telephone number, including area code: (650) 364-9975

________Dextera Surgical Inc., 900 Saginaw Drive, Redwood City, CA94063___________

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On each of January 22, 2018, February 20, 2018, March 20, 2018, and April 20, 2018, Dex Liquidating Co. (at that time Dextera Surgical Inc.) filed a Monthly Operating Report with the United States Bankruptcy Court for the District of Delaware, each for the month preceding the date of filing. These reports are filed as Exhibits 99.1, 99.2, 99.3 and 99.4, respectively.

Item 9.01.     Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description
99.1	Monthly Operating Report for the Month of December 2017.
99.2	Monthly Operating Report for the Month of January 2018.
99.3	Monthly Operating Report for the Month of February 2018.
99.4	Monthly Operating Report for the Month of March 2018.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Dextera Surgical Inc.
Date: May 4, 2018	By:	/s/ Matthew English
		Matthew English
		Chief Restructuring Officer

EX-99.1

Exhibit 99.1

EX-99.2

Exhibit 99.2

EX-99.3

Exhibit 99.3

EX-99.4

Exhibit 99.4